Optimizing surveillance strategies for sacrococcygeal teratoma: A Midwest pediatric surgery consortium multi-institutional study
Topic overview
Multi-institutional study of 178 pediatric SCT patients found 10% recurrence rate over median 2.88-year follow-up, with malignant histology as sole significant predictor (HR 5.83). Study recommends minimum 3-year surveillance protocol for lower-risk tumors, as most recurrences occurred within first 3 years post-resection.
Key takeaways
- 10% of pediatric SCT patients experienced recurrence during median 2.88-year follow-up; most recurrences occurred within first 3 years post-resection
- Malignant histopathology was the only significant predictor of recurrence (HR 5.83), while timing of diagnosis, resection completeness, and Altman classification were not
- Surveillance strategies varied significantly across 11 institutions with no standardized protocol for post-resection monitoring
- Minimum 3-year surveillance with imaging, tumor markers, and clinical exams recommended for lower-risk mature and immature teratomas
- Overall recurrence-free survival was 93.7% at 1 year, 88.8% at 3 years, and 88.8% at 5 years across all histologic subtypes
Comments